Mantena Research Centre Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 29-06-2024
- Paid Up Capital ₹ 2.50 Cr
as on 29-06-2024
- Company Age 18 Year, 9 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 6.00 M
as on 29-06-2024
- Revenue %
(FY 2019)
- Profit 3.42%
(FY 2019)
- Net Worth -0.02%
(FY 2019)
- Total Assets 1.24%
(FY 2019)
About Mantena Research Centre
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.50 Cr.
The company currently has active open charges totaling ₹6.00 M.
Ramakrishnavara Mantena and Sita Mantena serve as directors at the Company.
- CIN/LLPIN
U24110TG2006PTC049341
- Company No.
049341
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Mar 2006
- Date of AGM
14 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Mantena Research Centre?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramakrishnavara Mantena  | Managing Director | 01-Mar-2006 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sita Mantena | Director | 01-Mar-2006 | Current |
Financial Performance of Mantena Research Centre.
Mantena Research Centre Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 3.42% increase in profit. The company's net worth dipped by a decrease of 0.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Mantena Research Centre?
In 2017, Mantena Research Centre had a promoter holding of 50.88% and a public holding of 49.12%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Genie Pharm Haus Private LimitedActive 3 years 2 monthsRamakrishnavara Mantena and Sita Mantena are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 10 Feb 2011 | ₹6.00 M | Open |
How Many Employees Work at Mantena Research Centre?
Unlock and access historical data on people associated with Mantena Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mantena Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mantena Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
